Founded in 2010, Orpyx Medical Technologies empowers people with diabetes to maintain mobility. Orpyx’s core product line, SurroSense Rx®, helps prevent foot ulcers and limb loss through FDA cleared, advanced foot sensor technology and analytics, delivered in an easy-to use ultra-thin insole. Orpyx’s technology is used by researchers to access clinical-grade plantar pressure measurement data for health and human performance applications. Orpyx is focused on collaborating with stakeholders around the world to achieve a healthcare future that is prevention focused and sustainable in cost. Learn more at www.orpyx.com.